Member Info for Bladderman

Would not surprise me at all as this COVID high throughput production test is coming to the markets attention

I'd say anywhere between £50M and £500M depending on success and length of time as this global pandemic isnt going anywhere for 18 months

Looking very possible Technik..
Certainly should by tomorrow.

10,000 test production PER HOUR to be brought on line in under 4 weeks.
Ignore the 100p as is only £35M.
AVCT is 105p yet valued at £220M
Both massive potential but surely this is cheap.
ODX's also under going validation for their ELISA test and can do 46k per Day yet valued at £85M.
Do the maths guys

Come on Bench - we're still only valued at £34M. Has a long way to go as we all know so still 9-10x cheaper than NCYT

The herd has hit AVCT, ODX, NCYT and HEMO to name a few. We're now in the que. May is going to be a potential gamer changer here

RNS extract...."Genedrive's PCR chemistry integrated with Cytiva's LyoStable® stabilisation technology. The combination would allow for high throughput manufacturing of over 10,000 tests per hour in a 96-well, temperature-stable plate format that could be transported globally without the need for refrigeration. The one-step test features a single PCR bead that once mixed with a patient's sample, can be performed on a variety of existing open PCR platforms from manufactures such as Roche and ABI (Thermo Fisher)."

In collaboration with Cytiva (formerly GE Healthcare worth $2.3 billion) owned by Danaher Corporation with $21 billion. We should be valued at £40-£50M+ not £30M

It was NT to buy for long periods yesterday afternoon. The MMs are happy to collect but reluctant to let you buy back - I wonder why. They want your stock because this is going to be MASSIVE

Bench soon anything below £1 or £35M is going to look very cheap. Word is spreading and this outfit is about to be taken very seriously indeed

Someone mentioned HEMO which is also awesome but different to this and has done 200% in 24 hours. This has done about 20% in a week. Getting ready for our move onto £40M especially as now endorsed by Cytiva

8M tests a month production is insane for a £30M company. Remember it's test test test test said WHO. Easy money from these levels in the days weeks and months ahead

It's cheap enough at £30M.

In which case the business network and connections could already in place for promotion and delivery. These plates can be shipped and stored at ambient temps which clearly was a specific aim of the development process.
All coming together now.

Danaher Corporation.

You referring to Danaher company worth $21 billion...!! Nice.

Re-rate due

Compared to its peers

It's the tab above 'post a message'

Gee let me think a small market cap. What like a tenth of NCYT's. Umm - big YES